<?xml version='1.0' encoding='utf-8'?>
<response><mechanisms><mechanism><action_type>INHIBITOR</action_type><binding_site_comment/><direct_interaction>1</direct_interaction><disease_efficacy>1</disease_efficacy><max_phase>4</max_phase><mec_id>13</mec_id><mechanism_comment/><mechanism_of_action>Carbonic anhydrase VII inhibitor</mechanism_of_action><mechanism_refs><mechanism><ref_id>setid=8e162b6d-8fa6-45f6-80d8-5132d94c1207</ref_id><ref_type>DailyMed</ref_type><ref_url>http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e162b6d-8fa6-45f6-80d8-5132d94c1207</ref_url></mechanism><mechanism><ref_id>18336310</ref_id><ref_type>PubMed</ref_type><ref_url>http://europepmc.org/abstract/MED/18336310</ref_url></mechanism></mechanism_refs><molecular_mechanism>1</molecular_mechanism><molecule_chembl_id>CHEMBL19</molecule_chembl_id><parent_molecule_chembl_id>CHEMBL19</parent_molecule_chembl_id><record_id>1343810</record_id><selectivity_comment/><site_id/><target_chembl_id>CHEMBL2326</target_chembl_id><variant_sequence/></mechanism><mechanism><action_type>INHIBITOR</action_type><binding_site_comment/><direct_interaction>1</direct_interaction><disease_efficacy>1</disease_efficacy><max_phase>4</max_phase><mec_id>14</mec_id><mechanism_comment/><mechanism_of_action>Carbonic anhydrase I inhibitor</mechanism_of_action><mechanism_refs><mechanism><ref_id>1460006</ref_id><ref_type>PubMed</ref_type><ref_url>http://europepmc.org/abstract/MED/1460006</ref_url></mechanism></mechanism_refs><molecular_mechanism>1</molecular_mechanism><molecule_chembl_id>CHEMBL1201117</molecule_chembl_id><parent_molecule_chembl_id>CHEMBL1201117</parent_molecule_chembl_id><record_id>1344053</record_id><selectivity_comment/><site_id/><target_chembl_id>CHEMBL261</target_chembl_id><variant_sequence/></mechanism><mechanism><action_type>INHIBITOR</action_type><binding_site_comment/><direct_interaction>1</direct_interaction><disease_efficacy>1</disease_efficacy><max_phase>4</max_phase><mec_id>15</mec_id><mechanism_comment>Expressed in eye</mechanism_comment><mechanism_of_action>Carbonic anhydrase I inhibitor</mechanism_of_action><mechanism_refs><mechanism><ref_id>10713865</ref_id><ref_type>PubMed</ref_type><ref_url>http://europepmc.org/abstract/MED/10713865</ref_url></mechanism><mechanism><ref_id>18336310</ref_id><ref_type>PubMed</ref_type><ref_url>http://europepmc.org/abstract/MED/18336310</ref_url></mechanism></mechanism_refs><molecular_mechanism>1</molecular_mechanism><molecule_chembl_id>CHEMBL1200814</molecule_chembl_id><parent_molecule_chembl_id>CHEMBL20</parent_molecule_chembl_id><record_id>1344649</record_id><selectivity_comment/><site_id/><target_chembl_id>CHEMBL261</target_chembl_id><variant_sequence/></mechanism><mechanism><action_type>INHIBITOR</action_type><binding_site_comment/><direct_interaction>1</direct_interaction><disease_efficacy>1</disease_efficacy><max_phase>4</max_phase><mec_id>16</mec_id><mechanism_comment/><mechanism_of_action>Carbonic anhydrase I inhibitor</mechanism_of_action><mechanism_refs><mechanism><ref_id>18336310</ref_id><ref_type>PubMed</ref_type><ref_url>http://europepmc.org/abstract/MED/18336310</ref_url></mechanism></mechanism_refs><molecular_mechanism>1</molecular_mechanism><molecule_chembl_id>CHEMBL17</molecule_chembl_id><parent_molecule_chembl_id>CHEMBL17</parent_molecule_chembl_id><record_id>1343255</record_id><selectivity_comment/><site_id/><target_chembl_id>CHEMBL261</target_chembl_id><variant_sequence/></mechanism><mechanism><action_type>INHIBITOR</action_type><binding_site_comment/><direct_interaction>1</direct_interaction><disease_efficacy>1</disease_efficacy><max_phase>4</max_phase><mec_id>17</mec_id><mechanism_comment>Expressed in eye</mechanism_comment><mechanism_of_action>Carbonic anhydrase I inhibitor</mechanism_of_action><mechanism_refs><mechanism><ref_id>10713865</ref_id><ref_type>PubMed</ref_type><ref_url>http://europepmc.org/abstract/MED/10713865</ref_url></mechanism><mechanism><ref_id>18336310</ref_id><ref_type>PubMed</ref_type><ref_url>http://europepmc.org/abstract/MED/18336310</ref_url></mechanism></mechanism_refs><molecular_mechanism>1</molecular_mechanism><molecule_chembl_id>CHEMBL20</molecule_chembl_id><parent_molecule_chembl_id>CHEMBL20</parent_molecule_chembl_id><record_id>1344903</record_id><selectivity_comment/><site_id/><target_chembl_id>CHEMBL261</target_chembl_id><variant_sequence/></mechanism><mechanism><action_type>INHIBITOR</action_type><binding_site_comment/><direct_interaction>1</direct_interaction><disease_efficacy>1</disease_efficacy><max_phase>4</max_phase><mec_id>18</mec_id><mechanism_comment/><mechanism_of_action>Carbonic anhydrase I inhibitor</mechanism_of_action><mechanism_refs><mechanism><ref_id>setid=8e162b6d-8fa6-45f6-80d8-5132d94c1207</ref_id><ref_type>DailyMed</ref_type><ref_url>http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e162b6d-8fa6-45f6-80d8-5132d94c1207</ref_url></mechanism><mechanism><ref_id>18336310</ref_id><ref_type>PubMed</ref_type><ref_url>http://europepmc.org/abstract/MED/18336310</ref_url></mechanism></mechanism_refs><molecular_mechanism>1</molecular_mechanism><molecule_chembl_id>CHEMBL19</molecule_chembl_id><parent_molecule_chembl_id>CHEMBL19</parent_molecule_chembl_id><record_id>1343810</record_id><selectivity_comment/><site_id/><target_chembl_id>CHEMBL261</target_chembl_id><variant_sequence/></mechanism><mechanism><action_type>INHIBITOR</action_type><binding_site_comment/><direct_interaction>1</direct_interaction><disease_efficacy>1</disease_efficacy><max_phase>4</max_phase><mec_id>19</mec_id><mechanism_comment/><mechanism_of_action>Cytochrome b inhibitor</mechanism_of_action><mechanism_refs><mechanism><ref_id>setid=b426b6bf-f07e-4580-97ae-dfca1ddf5b8f</ref_id><ref_type>DailyMed</ref_type><ref_url>http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b426b6bf-f07e-4580-97ae-dfca1ddf5b8f#nlm34090-1</ref_url></mechanism><mechanism><ref_id>20855748</ref_id><ref_type>PubMed</ref_type><ref_url>http://europepmc.org/abstract/MED/20855748</ref_url></mechanism></mechanism_refs><molecular_mechanism>1</molecular_mechanism><molecule_chembl_id>CHEMBL1450</molecule_chembl_id><parent_molecule_chembl_id>CHEMBL1450</parent_molecule_chembl_id><record_id>1343336</record_id><selectivity_comment/><site_id/><target_chembl_id>CHEMBL1777</target_chembl_id><variant_sequence/></mechanism><mechanism><action_type>ANTAGONIST</action_type><binding_site_comment/><direct_interaction>1</direct_interaction><disease_efficacy>1</disease_efficacy><max_phase>4</max_phase><mec_id>20</mec_id><mechanism_comment>Role in regulating gastric secretion, M3 likely involved</mechanism_comment><mechanism_of_action>Muscarinic acetylcholine receptor M3 antagonist</mechanism_of_action><mechanism_refs><mechanism><ref_id>9780702034718 PP. 153</ref_id><ref_type>ISBN</ref_type><ref_url>http://www.isbnsearch.org/isbn/9780702034718</ref_url></mechanism><mechanism><ref_id>704660</ref_id><ref_type>PubMed</ref_type><ref_url>http://europepmc.org/abstract/MED/704660</ref_url></mechanism><mechanism><ref_id>Tridihexethyl_chloride</ref_id><ref_type>Wikipedia</ref_type><ref_url>http://en.wikipedia.org/wiki/Tridihexethyl_chloride</ref_url></mechanism></mechanism_refs><molecular_mechanism>1</molecular_mechanism><molecule_chembl_id>CHEMBL1200771</molecule_chembl_id><parent_molecule_chembl_id>CHEMBL1201354</parent_molecule_chembl_id><record_id>1343534</record_id><selectivity_comment/><site_id/><target_chembl_id>CHEMBL245</target_chembl_id><variant_sequence/></mechanism><mechanism><action_type>ANTAGONIST</action_type><binding_site_comment/><direct_interaction>1</direct_interaction><disease_efficacy>1</disease_efficacy><max_phase>4</max_phase><mec_id>21</mec_id><mechanism_comment>Indicated for overactive bladder, M3 likely responsible</mechanism_comment><mechanism_of_action>Muscarinic acetylcholine receptor M3 antagonist</mechanism_of_action><mechanism_refs><mechanism><ref_id>setid=5e29f133-270c-4e5a-8493-e038c163a891</ref_id><ref_type>DailyMed</ref_type><ref_url>http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e29f133-270c-4e5a-8493-e038c163a891</ref_url></mechanism><mechanism><ref_id>16465186</ref_id><ref_type>PubMed</ref_type><ref_url>http://europepmc.org/abstract/MED/16465186</ref_url></mechanism><mechanism><ref_id>Tolterodine#Pharmacology</ref_id><ref_type>Wikipedia</ref_type><ref_url>http://en.wikipedia.org/wiki/Tolterodine#Pharmacology</ref_url></mechanism></mechanism_refs><molecular_mechanism>1</molecular_mechanism><molecule_chembl_id>CHEMBL1722209</molecule_chembl_id><parent_molecule_chembl_id>CHEMBL1382</parent_molecule_chembl_id><record_id>1343271</record_id><selectivity_comment/><site_id/><target_chembl_id>CHEMBL245</target_chembl_id><variant_sequence/></mechanism><mechanism><action_type>ANTAGONIST</action_type><binding_site_comment/><direct_interaction>1</direct_interaction><disease_efficacy>1</disease_efficacy><max_phase>4</max_phase><mec_id>22</mec_id><mechanism_comment>Role in regulating gastric secretion and overactive bladded, M3 likely involved</mechanism_comment><mechanism_of_action>Muscarinic acetylcholine receptor M3 antagonist</mechanism_of_action><mechanism_refs><mechanism><ref_id>9780702034718 PP. 153</ref_id><ref_type>ISBN</ref_type><ref_url>http://www.isbnsearch.org/isbn/9780702034718</ref_url></mechanism><mechanism><ref_id>13263156</ref_id><ref_type>PubMed</ref_type><ref_url>http://europepmc.org/abstract/MED/13263156</ref_url></mechanism><mechanism><ref_id>16080359</ref_id><ref_type>PubMed</ref_type><ref_url>http://europepmc.org/abstract/MED/16080359</ref_url></mechanism><mechanism><ref_id>16465186</ref_id><ref_type>PubMed</ref_type><ref_url>http://europepmc.org/abstract/MED/16465186</ref_url></mechanism><mechanism><ref_id>3762265</ref_id><ref_type>PubMed</ref_type><ref_url>http://europepmc.org/abstract/MED/3762265</ref_url></mechanism><mechanism><ref_id>4381291</ref_id><ref_type>PubMed</ref_type><ref_url>http://europepmc.org/abstract/MED/4381291</ref_url></mechanism></mechanism_refs><molecular_mechanism>1</molecular_mechanism><molecule_chembl_id>CHEMBL1240</molecule_chembl_id><parent_molecule_chembl_id>CHEMBL1180725</parent_molecule_chembl_id><record_id>1343367</record_id><selectivity_comment/><site_id/><target_chembl_id>CHEMBL245</target_chembl_id><variant_sequence/></mechanism><mechanism><action_type>ANTAGONIST</action_type><binding_site_comment/><direct_interaction>1</direct_interaction><disease_efficacy>1</disease_efficacy><max_phase>4</max_phase><mec_id>23</mec_id><mechanism_comment>Indicated in mydriasis and regulating gastric secretion, M3 likely involved (main form in iris)</mechanism_comment><mechanism_of_action>Muscarinic acetylcholine receptor M3 antagonist</mechanism_of_action><mechanism_refs><mechanism><ref_id>9780702034718 PP. 153</ref_id><ref_type>ISBN</ref_type><ref_url>http://www.isbnsearch.org/isbn/9780702034718</ref_url></mechanism><mechanism><ref_id>1907331</ref_id><ref_type>PubMed</ref_type><ref_url>http://europepmc.org/abstract/MED/1907331</ref_url></mechanism></mechanism_refs><molecular_mechanism>1</molecular_mechanism><molecule_chembl_id>CHEMBL1200906</molecule_chembl_id><parent_molecule_chembl_id>CHEMBL1201286</parent_molecule_chembl_id><record_id>1344039</record_id><selectivity_comment/><site_id/><target_chembl_id>CHEMBL245</target_chembl_id><variant_sequence/></mechanism><mechanism><action_type>ANTAGONIST</action_type><binding_site_comment/><direct_interaction>1</direct_interaction><disease_efficacy>1</disease_efficacy><max_phase>4</max_phase><mec_id>24</mec_id><mechanism_comment>Role in regulating gastric secretion, M3 likely involved</mechanism_comment><mechanism_of_action>Muscarinic acetylcholine receptor M3 antagonist</mechanism_of_action><mechanism_refs><mechanism><ref_id>9780702034718 PP. 153</ref_id><ref_type>ISBN</ref_type><ref_url>http://www.isbnsearch.org/isbn/9780702034718</ref_url></mechanism><mechanism><ref_id>6345649</ref_id><ref_type>PubMed</ref_type><ref_url>http://europepmc.org/abstract/MED/6345649</ref_url></mechanism><mechanism><ref_id>7122991</ref_id><ref_type>PubMed</ref_type><ref_url>http://europepmc.org/abstract/MED/7122991</ref_url></mechanism></mechanism_refs><molecular_mechanism>1</molecular_mechanism><molecule_chembl_id>CHEMBL1724</molecule_chembl_id><parent_molecule_chembl_id>CHEMBL524004</parent_molecule_chembl_id><record_id>1343841</record_id><selectivity_comment/><site_id/><target_chembl_id>CHEMBL245</target_chembl_id><variant_sequence/></mechanism><mechanism><action_type>ANTAGONIST</action_type><binding_site_comment/><direct_interaction>1</direct_interaction><disease_efficacy>1</disease_efficacy><max_phase>4</max_phase><mec_id>25</mec_id><mechanism_comment>Role in regulating gastric secretion, M3 likely involved</mechanism_comment><mechanism_of_action>Muscarinic acetylcholine receptor M3 antagonist</mechanism_of_action><mechanism_refs><mechanism><ref_id>9780702034718 PP. 153</ref_id><ref_type>ISBN</ref_type><ref_url>http://www.isbnsearch.org/isbn/9780702034718</ref_url></mechanism><mechanism><ref_id>8075869</ref_id><ref_type>PubMed</ref_type><ref_url>http://europepmc.org/abstract/MED/8075869</ref_url></mechanism><mechanism><ref_id>9183081</ref_id><ref_type>PubMed</ref_type><ref_url>http://europepmc.org/abstract/MED/9183081</ref_url></mechanism></mechanism_refs><molecular_mechanism>1</molecular_mechanism><molecule_chembl_id>CHEMBL1626570</molecule_chembl_id><parent_molecule_chembl_id>CHEMBL1201325</parent_molecule_chembl_id><record_id>1343451</record_id><selectivity_comment/><site_id/><target_chembl_id>CHEMBL245</target_chembl_id><variant_sequence/></mechanism><mechanism><action_type>ANTAGONIST</action_type><binding_site_comment/><direct_interaction>1</direct_interaction><disease_efficacy>1</disease_efficacy><max_phase>4</max_phase><mec_id>26</mec_id><mechanism_comment>Role in regulating gastric secretion, M3 likely involved</mechanism_comment><mechanism_of_action>Muscarinic acetylcholine receptor M3 antagonist</mechanism_of_action><mechanism_refs><mechanism><ref_id>9780702034718 PP. 153</ref_id><ref_type>ISBN</ref_type><ref_url>http://www.isbnsearch.org/isbn/9780702034718</ref_url></mechanism><mechanism><ref_id>13478170</ref_id><ref_type>PubMed</ref_type><ref_url>http://europepmc.org/abstract/MED/13478170</ref_url></mechanism></mechanism_refs><molecular_mechanism>1</molecular_mechanism><molecule_chembl_id>CHEMBL1200880</molecule_chembl_id><parent_molecule_chembl_id>CHEMBL1201340</parent_molecule_chembl_id><record_id>1344767</record_id><selectivity_comment/><site_id/><target_chembl_id>CHEMBL245</target_chembl_id><variant_sequence/></mechanism><mechanism><action_type>ANTAGONIST</action_type><binding_site_comment/><direct_interaction>1</direct_interaction><disease_efficacy>1</disease_efficacy><max_phase>4</max_phase><mec_id>27</mec_id><mechanism_comment>Indicated in irritable bowel, M3 likely involved</mechanism_comment><mechanism_of_action>Muscarinic acetylcholine receptor M3 antagonist</mechanism_of_action><mechanism_refs><mechanism><ref_id>setid=c56598d5-9cd1-4cce-b172-ac338775aec7</ref_id><ref_type>DailyMed</ref_type><ref_url>http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c56598d5-9cd1-4cce-b172-ac338775aec7</ref_url></mechanism><mechanism><ref_id>9780702034718 PP. 153</ref_id><ref_type>ISBN</ref_type><ref_url>http://www.isbnsearch.org/isbn/9780702034718</ref_url></mechanism></mechanism_refs><molecular_mechanism>1</molecular_mechanism><molecule_chembl_id>CHEMBL1200479</molecule_chembl_id><parent_molecule_chembl_id>CHEMBL1123</parent_molecule_chembl_id><record_id>1343131</record_id><selectivity_comment/><site_id/><target_chembl_id>CHEMBL245</target_chembl_id><variant_sequence/></mechanism><mechanism><action_type>AGONIST</action_type><binding_site_comment/><direct_interaction>1</direct_interaction><disease_efficacy>1</disease_efficacy><max_phase>4</max_phase><mec_id>28</mec_id><mechanism_comment>Indicated for urinary retention, M3 likely responsible</mechanism_comment><mechanism_of_action>Muscarinic acetylcholine receptor M3 agonist</mechanism_of_action><mechanism_refs><mechanism><ref_id>9780702034718 PP. 157</ref_id><ref_type>ISBN</ref_type><ref_url>http://www.isbnsearch.org/isbn/9780702034718</ref_url></mechanism><mechanism><ref_id>16465186</ref_id><ref_type>PubMed</ref_type><ref_url>http://europepmc.org/abstract/MED/16465186</ref_url></mechanism><mechanism><ref_id>982732</ref_id><ref_type>PubMed</ref_type><ref_url>http://europepmc.org/abstract/MED/982732</ref_url></mechanism><mechanism><ref_id>Bethanechol</ref_id><ref_type>Wikipedia</ref_type><ref_url>http://en.wikipedia.org/wiki/Bethanechol</ref_url></mechanism></mechanism_refs><molecular_mechanism>1</molecular_mechanism><molecule_chembl_id>CHEMBL1768</molecule_chembl_id><parent_molecule_chembl_id>CHEMBL1482</parent_molecule_chembl_id><record_id>1343595</record_id><selectivity_comment/><site_id/><target_chembl_id>CHEMBL245</target_chembl_id><variant_sequence/></mechanism><mechanism><action_type>ANTAGONIST</action_type><binding_site_comment/><direct_interaction>1</direct_interaction><disease_efficacy>1</disease_efficacy><max_phase>4</max_phase><mec_id>29</mec_id><mechanism_comment>Role in regulating gastric secretion, M3 likely involved</mechanism_comment><mechanism_of_action>Muscarinic acetylcholine receptor M3 antagonist</mechanism_of_action><mechanism_refs><mechanism><ref_id>353090</ref_id><ref_type>PubMed</ref_type><ref_url>http://europepmc.org/abstract/MED/353090</ref_url></mechanism><mechanism><ref_id>4555460</ref_id><ref_type>PubMed</ref_type><ref_url>http://europepmc.org/abstract/MED/4555460</ref_url></mechanism><mechanism><ref_id>Anisotropine_Methylbromide</ref_id><ref_type>Wikipedia</ref_type><ref_url>http://en.wikipedia.org/wiki/Anisotropine_Methylbromide</ref_url></mechanism></mechanism_refs><molecular_mechanism>1</molecular_mechanism><molecule_chembl_id>CHEMBL1578</molecule_chembl_id><parent_molecule_chembl_id>CHEMBL1186610</parent_molecule_chembl_id><record_id>1344400</record_id><selectivity_comment/><site_id/><target_chembl_id>CHEMBL245</target_chembl_id><variant_sequence/></mechanism><mechanism><action_type>ANTAGONIST</action_type><binding_site_comment/><direct_interaction>1</direct_interaction><disease_efficacy>1</disease_efficacy><max_phase>4</max_phase><mec_id>30</mec_id><mechanism_comment>Indicated for mydriasis and regulating gastric secretion, M3 likely involved (main form in iris)</mechanism_comment><mechanism_of_action>Muscarinic acetylcholine receptor M3 antagonist</mechanism_of_action><mechanism_refs><mechanism><ref_id>label/2004/17106s032lbl.pdf</ref_id><ref_type>FDA</ref_type><ref_url>http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/17106s032lbl.pdf</ref_url></mechanism><mechanism><ref_id>9780702034718 PP. 159</ref_id><ref_type>ISBN</ref_type><ref_url>http://www.isbnsearch.org/isbn/9780702034718</ref_url></mechanism><mechanism><ref_id>Atropine</ref_id><ref_type>Wikipedia</ref_type><ref_url>http://en.wikipedia.org/wiki/Atropine</ref_url></mechanism></mechanism_refs><molecular_mechanism>1</molecular_mechanism><molecule_chembl_id>CHEMBL2146146</molecule_chembl_id><parent_molecule_chembl_id>CHEMBL517712</parent_molecule_chembl_id><record_id>1343115</record_id><selectivity_comment/><site_id/><target_chembl_id>CHEMBL245</target_chembl_id><variant_sequence/></mechanism><mechanism><action_type>ANTAGONIST</action_type><binding_site_comment/><direct_interaction>1</direct_interaction><disease_efficacy>1</disease_efficacy><max_phase>4</max_phase><mec_id>31</mec_id><mechanism_comment>Indicated for mydriasis and regulating gastric secretion, M3 likely involved (main form in iris)</mechanism_comment><mechanism_of_action>Muscarinic acetylcholine receptor M3 antagonist</mechanism_of_action><mechanism_refs><mechanism><ref_id>label/2004/17106s032lbl.pdf</ref_id><ref_type>FDA</ref_type><ref_url>http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/17106s032lbl.pdf</ref_url></mechanism><mechanism><ref_id>9780702034718 PP. 159</ref_id><ref_type>ISBN</ref_type><ref_url>http://www.isbnsearch.org/isbn/9780702034718</ref_url></mechanism><mechanism><ref_id>Atropine</ref_id><ref_type>Wikipedia</ref_type><ref_url>http://en.wikipedia.org/wiki/Atropine</ref_url></mechanism></mechanism_refs><molecular_mechanism>1</molecular_mechanism><molecule_chembl_id>CHEMBL517712</molecule_chembl_id><parent_molecule_chembl_id>CHEMBL517712</parent_molecule_chembl_id><record_id>1344620</record_id><selectivity_comment/><site_id/><target_chembl_id>CHEMBL245</target_chembl_id><variant_sequence/></mechanism><mechanism><action_type>ANTAGONIST</action_type><binding_site_comment/><direct_interaction>1</direct_interaction><disease_efficacy>1</disease_efficacy><max_phase>4</max_phase><mec_id>32</mec_id><mechanism_comment>Indicated for mydriasis, M3 likely involved (main form in iris)</mechanism_comment><mechanism_of_action>Muscarinic acetylcholine receptor M3 antagonist</mechanism_of_action><mechanism_refs><mechanism><ref_id>9780702034718 PP. 153, 160</ref_id><ref_type>ISBN</ref_type><ref_url>http://www.isbnsearch.org/isbn/9780702034718</ref_url></mechanism><mechanism><ref_id>1111414</ref_id><ref_type>PubMed</ref_type><ref_url>http://europepmc.org/abstract/MED/1111414</ref_url></mechanism><mechanism><ref_id>17579880</ref_id><ref_type>PubMed</ref_type><ref_url>http://europepmc.org/abstract/MED/17579880</ref_url></mechanism></mechanism_refs><molecular_mechanism>1</molecular_mechanism><molecule_chembl_id>CHEMBL1200604</molecule_chembl_id><parent_molecule_chembl_id>CHEMBL1200604</parent_molecule_chembl_id><record_id>1343683</record_id><selectivity_comment/><site_id/><target_chembl_id>CHEMBL245</target_chembl_id><variant_sequence/></mechanism></mechanisms><page_meta><limit>20</limit><next>/chembl/api/data/mechanism?limit=20&amp;offset=20</next><offset/><previous/><total_count>7568</total_count></page_meta></response>